Shell Asset Management’s Acceleron Pharma XLRN Stock Holding History

Shell Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,870	Closed	-$494K	–	1427
2021 Q3	$494K	Sell	2,870 -130	-4%	-$17K	0.01%	871
2021 Q2	$376K	Buy	3,000 +1,011	+51%	+$128K	0.01%	1037
2021 Q1	$270K	Sell	1,989 -1,976	-50%	-$255K	0.01%	1065
2020 Q4	$507K	Buy	3,965 +2,112	+114%	+$248K	0.01%	797
2020 Q3	$209K	Buy	+1,853	New	+$184K	﹤0.01%	1032

Shell Asset Management's XLRN Position: Q4 2021 in Review

Shell Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,870 shares — an estimated $494K sold.

Shell Asset Management first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $507K in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Shell Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Shell Asset Management sold 2,870 Acceleron Pharma shares in Q4 2021, an estimated $494K.
Shell Asset Management first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
Shell Asset Management's Acceleron Pharma position peaked at $507K in Q4 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Shell Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.